Literature DB >> 31089983

Inhibition of CBP/β-catenin and porcupine attenuates Wnt signaling and induces apoptosis in head and neck carcinoma cells.

Robert Kleszcz1, Anna Szymańska1, Violetta Krajka-Kuźniak1, Wanda Baer-Dubowska1, Jarosław Paluszczak2.   

Abstract

PURPOSE: Activation of the Wnt pathway contributes to the development of head and neck squamous cell carcinomas (HNSCC) and its inhibition has recently emerged as a promising therapeutic strategy. Here, we aimed at identifying suitable molecular targets for down-regulation of canonical Wnt signaling in HNSCC cells.
METHODS: Candidate target genes (PORCN, WNT3A, FZD2, FZD5, LRP5, DVL1, CIP2A, SET, KDM1A, KDM4C, KDM6A, CBP, CARM1, KMT2A, TCF7, LEF1, PYGO1, XIAP) were silenced using siRNA and selected targets were subsequently blocked using small molecule inhibitors. The effect of this treatment on the expression of β-catenin-dependent genes was assessed by qRT-PCR. The effect of the inhibitors on cell viability was evaluated using a resazurin assay in HNSCC-derived cell lines. A luciferase reporter assay was used for confirmation of the inhibition of Wnt-dependent gene expression. Cell migration was evaluated using a scratch wound healing assay. Cytometric analysis of propidium iodide stained cells was used for cell cycle distribution evaluation, whereas cytometric analysis of caspase 3/7 activity was used for apoptosis induction evaluation.
RESULTS: We found that inhibition of Porcupine and CBP/β-catenin interaction by IWP-2 and PRI-724, respectively, most strongly affected β-catenin-dependent gene expression in HNSCC cells. These inhibitors also induced apoptosis and affected HNSCC cell migration.
CONCLUSIONS: Targeting Porcupine or the CBP/β-catenin interaction seems to be an effective strategy for the inhibition of canonical Wnt signaling in HNSCC cells. Further studies are required to confirm the possible therapeutic effect of IWP-2 and PRI-724 in HNSCC.

Entities:  

Keywords:  CBP; Head and neck cancer; IWP-2; PRI-724; Porcupine; Wnt pathway

Mesh:

Substances:

Year:  2019        PMID: 31089983     DOI: 10.1007/s13402-019-00440-4

Source DB:  PubMed          Journal:  Cell Oncol (Dordr)        ISSN: 2211-3428            Impact factor:   6.730


  10 in total

1.  WNT1, a target of miR-34a, promotes cervical squamous cell carcinoma proliferation and invasion by induction of an E-P cadherin switch via the WNT/β-catenin pathway.

Authors:  Baohua Li; Xuedong Guo; Na Li; Qin Chen; Junhua Shen; Xiaoxiu Huang; Genping Huang; Fenfen Wang
Journal:  Cell Oncol (Dordr)       Date:  2020-04-16       Impact factor: 6.730

2.  Identification and potential mechanisms of a 4-lncRNA signature that predicts prognosis in patients with laryngeal cancer.

Authors:  Guihai Zhang; Erxi Fan; Qiuyue Zhong; Guangyong Feng; Yu Shuai; Mingna Wu; Qiying Chen; Xiaoxia Gou
Journal:  Hum Genomics       Date:  2019-08-15       Impact factor: 4.639

3.  Porcupine Inhibitor LGK974 Downregulates the Wnt Signaling Pathway and Inhibits Clear Cell Renal Cell Carcinoma.

Authors:  Jianyi Li; Guangzhen Wu; Yingkun Xu; Jiatong Li; Ningke Ruan; Yougen Chen; Qi Zhang; Qinghua Xia
Journal:  Biomed Res Int       Date:  2020-02-13       Impact factor: 3.411

Review 4.  Targeting the Wnt/β-catenin signaling pathway in cancer.

Authors:  Ya Zhang; Xin Wang
Journal:  J Hematol Oncol       Date:  2020-12-04       Impact factor: 17.388

5.  Targeting of Deregulated Wnt/β-Catenin Signaling by PRI-724 and LGK974 Inhibitors in Germ Cell Tumor Cell Lines.

Authors:  Silvia Schmidtova; Katarina Kalavska; Veronika Liskova; Jana Plava; Svetlana Miklikova; Lucia Kucerova; Miroslava Matuskova; Lucia Rojikova; Zuzana Cierna; Adriana Rogozea; Heiko Konig; Costantine Albany; Michal Mego; Michal Chovanec
Journal:  Int J Mol Sci       Date:  2021-04-20       Impact factor: 5.923

Review 6.  Wnt/β-catenin signaling in cancers and targeted therapies.

Authors:  Fanyuan Yu; Changhao Yu; Feifei Li; Yanqin Zuo; Yitian Wang; Lin Yao; Chenzhou Wu; Chenglin Wang; Ling Ye
Journal:  Signal Transduct Target Ther       Date:  2021-08-30

7.  The Wnt Signaling Pathway Inhibitors Improve the Therapeutic Activity of Glycolysis Modulators against Tongue Cancer Cells.

Authors:  Robert Kleszcz; Jarosław Paluszczak
Journal:  Int J Mol Sci       Date:  2022-01-23       Impact factor: 5.923

Review 8.  The Significance of the Dysregulation of Canonical Wnt Signaling in Head and Neck Squamous Cell Carcinomas.

Authors:  Jarosław Paluszczak
Journal:  Cells       Date:  2020-03-15       Impact factor: 6.600

Review 9.  Oral Cancer Stem Cells: Therapeutic Implications and Challenges.

Authors:  Linah A Shahoumi
Journal:  Front Oral Health       Date:  2021-07-21

Review 10.  The Emerging Significance of Histone Lysine Demethylases as Prognostic Markers and Therapeutic Targets in Head and Neck Cancers.

Authors:  Dawid Dorna; Jarosław Paluszczak
Journal:  Cells       Date:  2022-03-17       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.